Pharma-Bio Serv, Inc. (PBSV) Form 10-Q Quarterly Reports
Pharma-Bio Serv, Inc. (PBSV) is a publicly traded company on the OTC, categorized under SIC 8742 (Services-Management Consulting Services). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PBSV
CIK: 1304161
Exchange: OTC
SIC 8742: Services-Management Consulting Services
Fiscal Year End: 10/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Crowe PR PSC
Auditor SinceSince 10/31/2018 12:00:00 AM
Lead Engagement PartnerJose Penabaz
Audit LocationGuaynabo, Puerto Rico, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-14 | 2026-09-14 | FORM 8-K | 0001654954-26-008347 | View SEC Doc Filr Page |
| 10-Q | 2026-09-14 | 2026-07-31 | FORM 10-Q | 0001654954-26-008346 | View SEC Doc Filr Page |
| 4 | 2026-07-22 | 2026-06-09 | PRIMARY DOCUMENT | 0001654954-26-006801 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-15 | FORM 8-K | 0001654954-26-005989 | View SEC Doc Filr Page |
| 10-Q | 2026-06-15 | 2026-04-30 | FORM 10-Q | 0001654954-26-005986 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | FORM 8-K | 0001654954-26-005006 | View SEC Doc Filr Page |
| ARS | 2026-04-16 | 2025-10-31 | ARS | 0001654954-26-003618 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-16 | 2026-04-15 | DEF 14A | 0001654954-26-003617 | View SEC Doc Filr Page |
| 8-K | 2026-03-17 | 2026-03-17 | FORM 8-K | 0001654954-26-002338 | View SEC Doc Filr Page |
| 10-Q | 2026-03-17 | 2026-01-31 | FORM 10-Q | 0001654954-26-002336 | View SEC Doc Filr Page |
| 10-K/A | 2026-02-27 | 2025-10-31 | FORM 10-K/A | 0001654954-26-001674 | View SEC Doc Filr Page |
| 8-K | 2026-01-29 | 2026-01-29 | FORM 8-K | 0001654954-26-000712 | View SEC Doc Filr Page |
| 10-K | 2026-01-29 | 2025-10-31 | FORM 10-K | 0001654954-26-000710 | View SEC Doc Filr Page |
| 4 | 2026-01-14 | 2026-01-10 | FORM 4 | 0001654954-26-000353 | View SEC Doc Filr Page |
| 4 | 2026-01-14 | 2026-01-10 | FORM 4 | 0001654954-26-000352 | View SEC Doc Filr Page |
| 4 | 2026-01-14 | 2026-01-10 | FORM 4 | 0001654954-26-000349 | View SEC Doc Filr Page |
| 4 | 2026-01-14 | 2026-01-10 | FORM 4 | 0001654954-26-000347 | View SEC Doc Filr Page |
| 8-K | 2025-09-15 | 2025-09-15 | FORM 8-K | 0001654954-25-010776 | View SEC Doc Filr Page |
| 10-Q | 2025-09-15 | 2025-07-31 | FORM 10-Q | 0001654954-25-010775 | View SEC Doc Filr Page |
| 8-K | 2025-06-16 | 2025-06-16 | FORM 8-K | 0001654954-25-007011 | View SEC Doc Filr Page |
| 10-Q | 2025-06-16 | 2025-04-30 | FORM 10-Q | 0001654954-25-007009 | View SEC Doc Filr Page |
| 8-K | 2025-05-16 | 2025-05-15 | FORM 8-K | 0001654954-25-005812 | View SEC Doc Filr Page |
| ARS | 2025-04-21 | 2024-10-31 | ARS | 0001654954-25-004487 | View SEC Doc Filr Page |
| DEF 14A | 2025-04-21 | 2025-04-12 | DEF 14A | 0001654954-25-004485 | View SEC Doc Filr Page |
| 8-K | 2025-03-17 | 2025-03-17 | FORM 8-K | 0001654954-25-002892 | View SEC Doc Filr Page |